Our data suggest that chronic ACE2 over-expression in the brain decreased Ang-II-mediated cardiac hypertrophy and collagen deposition, reduced urinary norepinephrine levels and partially protected SA transgenic mice from sympathetic -mediated cardiac hypertrophy and fibrosis. This evidence concerns the gene ACE2 and cardiac hypertrophy.